Among the 12 genes of the ACEsig, CALCRL, a G-protein-coupled neuropeptide receptor, and HOPX, a transcription factor involving in regulating differentiation, have both been associated with a poorer prognosis across multiple AML cohorts [67–69]. This evidence concerns the gene HOPX and acute myeloid leukemia.